Target intelligence / Profile preview

Mitogen-activated protein kinase kinase kinase 5 (MAP3K5)

Target
MAP3K5
Molecular classification
Enzyme, Kinase, Serine/threonine-protein kinase, Mitogen-activated protein kinase kinase kinase
01

Overview

Mitogen-activated protein kinase kinase kinase 5 (MAP3K5), widely known as Apoptosis signal-regulating kinase 1 (ASK1), is a key serine/threonine kinase that functions as an upstream regulator in the mitogen-activated protein kinase (MAPK) signaling cascade. Under physiological conditions, MAP3K5 is kept inactive through its association with reduced thioredoxin (Trx). However, in response to cellular stressors such as oxidative stress, endoplasmic reticulum (ER) stress, and inflammatory cytokines (e.g., TNF-alpha), Trx dissociates, allowing MAP3K5 to undergo homodimerization and autophosphorylation. Once activated, MAP3K5 phosphorylates downstream MAP kinase kinases (MKK3/6 and MKK4/7), which subsequently activate the p38 and JNK pathways to drive apoptosis, inflammation, and fibrosis.

Due to its central role in mediating stress-induced cell death and tissue remodeling, MAP3K5 has emerged as a highly attractive therapeutic target for chronic inflammatory, fibrotic, and degenerative diseases. Small-molecule inhibitors, such as selonsertib (GS-4997), have been developed to target the ATP-binding site of the kinase domain, blocking downstream signaling. Although clinical trials of selonsertib in nonalcoholic steatohepatitis (NASH) and pulmonary arterial hypertension failed to meet primary efficacy endpoints, MAP3K5 inhibition has shown therapeutic potential in slowing the progression of diabetic kidney disease (DKD). Notable clinical challenges include a transient, benign increase in serum creatinine due to the inhibition of renal creatinine transporters, which can confound early assessments of kidney function.

Other names
Apoptosis signal-regulating kinase 1ASK1ASK-1MAPK/ERK kinase kinase 5MEK kinase 5MEKK5MAPKKK5
02

Mechanism of action

ATP-competitive inhibition of the catalytic kinase domain of MAP3K5/ASK1, preventing its autophosphorylation and downstream phosphorylation of MKK3/MKK6 and MKK4/MKK7, thereby blocking the activation of p38 MAPK and JNK signaling pathways.

03

Biological functions

Signal transductionApoptosisCell deathImmune responseCell differentiationInflammatory responseOxidative stress response
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseInflammationCancerDiabetic kidney diseaseNonalcoholic steatohepatitis (NASH)Liver fibrosisPulmonary arterial hypertension
05

Safety considerations

Inhibition of renal creatinine secretion (causing a transient, benign increase in serum creatinine and acute eGFR decline, which can confound kidney function assessment)Potential for hepatotoxicity or off-target effects with early-generation inhibitorsRisk of impairing host defense/innate immune response due to its role in pathogen sensingPotential risk of promoting tumorigenesis in certain contexts due to its role in eliminating senescent cells
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Phosphorylated p38 (p-p38)Phosphorylated ASK1 (pASK1)eGFR (estimated glomerular filtration rate)Plasma proteome signatureSerum biomarkers of apoptosis and necrosisLiver stiffness

Beyond the preview

Go deeper on Mitogen-activated protein kinase kinase kinase 5 (MAP3K5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitogen-activated protein kinase kinase kinase 5 (MAP3K5).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call